These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22875708)
1. Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma. Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF J Neurooncol; 2012 Nov; 110(2):227-35. PubMed ID: 22875708 [TBL] [Abstract][Full Text] [Related]
2. Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide. Shonka NA; Theeler B; Cahill D; Yung A; Smith L; Lei X; Gilbert MR J Neurooncol; 2013 Jun; 113(2):305-11. PubMed ID: 23526410 [TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. Chang S; Zhang P; Cairncross JG; Gilbert MR; Bahary JP; Dolinskas CA; Chakravarti A; Aldape KD; Bell EH; Schiff D; Jaeckle K; Brown PD; Barger GR; Werner-Wasik M; Shih H; Brachman D; Penas-Prado M; Robins HI; Belanger K; Schultz C; Hunter G; Mehta M Neuro Oncol; 2017 Feb; 19(2):252-258. PubMed ID: 27994066 [TBL] [Abstract][Full Text] [Related]
4. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233 [TBL] [Abstract][Full Text] [Related]
5. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study. Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562 [TBL] [Abstract][Full Text] [Related]
6. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331 [TBL] [Abstract][Full Text] [Related]
7. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R; Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067 [TBL] [Abstract][Full Text] [Related]
8. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269 [TBL] [Abstract][Full Text] [Related]
9. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. Kizilbash SH; Giannini C; Voss JS; Decker PA; Jenkins RB; Hardie J; Laack NN; Parney IF; Uhm JH; Buckner JC J Neurooncol; 2014 Oct; 120(1):85-93. PubMed ID: 24993250 [TBL] [Abstract][Full Text] [Related]
10. High-grade glioma in children and adolescents: a single-center experience. Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience. Mayer A; Schwanbeck C; Sommer C; Stockinger M; Giese A; Renovanz M; Vaupel P; Schmidberger H Strahlenther Onkol; 2015 Aug; 191(8):665-71. PubMed ID: 26025143 [TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. Minniti G; De Sanctis V; Muni R; Rasio D; Lanzetta G; Bozzao A; Osti MF; Salvati M; Valeriani M; Cantore GP; Maurizi Enrici R J Neurooncol; 2009 Jan; 91(1):95-100. PubMed ID: 18758912 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Vogelbaum MA; Berkey B; Peereboom D; Macdonald D; Giannini C; Suh JH; Jenkins R; Herman J; Brown P; Blumenthal DT; Biggs C; Schultz C; Mehta M Neuro Oncol; 2009 Apr; 11(2):167-75. PubMed ID: 18779504 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma. Minniti G; Paolini S; Antonelli M; Gianno F; Tini P; Lanzetta G; Arcella A; De Pietro R; Giraffa M; Capone L; Romano A; Bozzao A; Esposito V J Neurooncol; 2023 Sep; 164(2):331-339. PubMed ID: 37665475 [TBL] [Abstract][Full Text] [Related]
16. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
17. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Wick W; Platten M; Meisner C; Felsberg J; Tabatabai G; Simon M; Nikkhah G; Papsdorf K; Steinbach JP; Sabel M; Combs SE; Vesper J; Braun C; Meixensberger J; Ketter R; Mayer-Steinacker R; Reifenberger G; Weller M; Lancet Oncol; 2012 Jul; 13(7):707-15. PubMed ID: 22578793 [TBL] [Abstract][Full Text] [Related]
18. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161 [TBL] [Abstract][Full Text] [Related]
19. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726 [TBL] [Abstract][Full Text] [Related]
20. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]